Company intelligence / Profile preview

MiniStim

Boca Raton, Florida, United Statesministim.com ↗

Ownership: Private
Development stage: Other

Overview

MiniStim has developed an FDA-cleared percutaneous implantable pulse generator system for peripheral nerve stimulation. The device is designed to be minimally invasive and is indicated for adults with severe intractable chronic pain of peripheral nerve origin. It is currently being studied further in clinical trials targeting specific indications such as chronic knee pain after surgery, hip/SI joint pain, and diabetic neuropathy.

Therapeutic areas: NeurologyEndocrinology
Modalities: DeviceNon-pharmacological therapy
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on MiniStim.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MiniStim.

Explore the full profile